Skip to main content
. Author manuscript; available in PMC: 2021 Jul 14.
Published in final edited form as: Vaccine. 2020 Jun 19;38(33):5119–5122. doi: 10.1016/j.vaccine.2020.05.056

Table 1.

Sample Characteristics by HPV Receipt and Adherence Young Adults (Age 18–29 years) from Nine States Behavior Risk Factor Surveillance System, 2015

ALL HPV Doses 1–2 HPV Doses No HPV dose
N Wt. % N Wt. % N Wt. % Chi-Sq Prob
ALL 815 427 2638
Sex 148.869 <0.0001
 Female 703 31.5 267 15.3 1061 53.3
 Male 112 4.2 160 9.3 1577 86.5
Race/Ethnicity 15.401 0.052
 Non-Hispanic White 624 21.4 235 10.1 1703 68.6
 African American 62 10.9 76 12.2 348 76.9
 Hispanic 68 13.2 70 15.0 390 71.7
 Other race 56 18.7 36 17.3 154 64.0
 Missing 5 14.0 10 14.2 43 71.9
Age Group 61.323 0.000
 18–24 Years 535 21.6 296 16.4 1276 62.0
 25–29 Years 280 11.1 131 5.8 1362 83.1
Influenza Immunizations 32.521 <0.0001
 Yes, past year 344 25.0 157 15.1 630 59.8
 No 469 14.9 267 11.0 1997 74.2
 Missing 2 3.5 3 46.3 11 50.2
Region 40.203 <0.0001
 Northeast 278 29.7 120 13.0 601 57.3
 Midwest 77 18.3 39 11.0 295 70.7
 South 380 15.6 218 12.3 1485 72.1
 West 80 21.3 50 10.2 257 68.5

Note: Based on 3,880 young adults in the age group 18–29 years from nine states and who did not have missing values in human papillomavirus vaccination variable. Significant group differences were tested with Rao-Scott chi-squares.

HPV: Human Papillomavirus Vaccination